Among emerging biomarkers, the soluble form of the urokinase plasminogen activator receptor (suPAR) holds promise, as it has been found to specifically identify patients at risk for postoperative sepsis, independent of specific organ failures [11]. Here, PLAUR is linked to Sepsis.